
Virbac cuts its 2023 growth and adjusted EBIT guidance ($VIRP)
Virbac ($VIRP) lowers its 2023 guidance: growth cut to 0-4% and EBIT to 12-13%. Multi-timeframe technical analysis and price targets.
EliteProfit
Read More
4 min read

Virbac ($VIRP) lowers its 2023 guidance: growth cut to 0-4% and EBIT to 12-13%. Multi-timeframe technical analysis and price targets.

Capgemini ($CAP) extends its Google Cloud partnership on generative AI. Announcement effect or real news? Multi-timeframe technical analysis and key levels.